[
    {
        "document": "Thiazolidinediones (TZDs) are peroxisomal proliferator-activated receptor (PPAR)-gamma agonists.",
        "tokens": [
            {
                "text": "Thiazolidinediones (TZDs)",
                "start": 0,
                "end": 25,
                "token_start": 0,
                "token_end": 3,
                "entityLabel": "Organic Chemical"
            },
            {
                "text": "peroxisomal proliferator-activated receptor (PPAR)-gamma agonists",
                "start": 30,
                "end": 95,
                "token_start": 5,
                "token_end": 12,
                "entityLabel": "P"
            }
        ],
        "relations": [
            {
                "child": 5,
                "head": 0,
                "relationLabel": "ISA"
            }
        ]
    },
    {
        "document": "Other, as yet, unapproved uses of TZDs include: non-alcoholic fatty liver disease, in which TZDs reduced hepatic fat accumulation and improved liver function tests; polycystic ovary syndrome, where TZDs improved ovulation, hirsutism and endothelial dysfunction; and lipodystrophies, where TZDs increased body fat (marginally) and decrease liver size.",
        "tokens": [
            {
                "text": "TZDs",
                "start": 34,
                "end": 38,
                "token_start": 8,
                "token_end": 8,
                "entityLabel": "Organic Chemical"
            },
            {
                "text": "disease",
                "start": 74,
                "end": 81,
                "token_start": 14,
                "token_end": 14,
                "entityLabel": "D"
            },
            {
                "text": "non-alcoholic fatty liver",
                "start": 48,
                "end": 73,
                "token_start": 11,
                "token_end": 15,
                "entityLabel": "D"
            },
            {
                "text": "hepatic fat accumulation",
                "start": 105,
                "end": 129,
                "token_start": 20,
                "token_end": 22,
                "entityLabel": "F"
            },
            {
                "text": "polycystic ovary syndrome",
                "start": 165,
                "end": 190,
                "token_start": 29,
                "token_end": 31,
                "entityLabel": "D"
            },
            {
                "text": "ovulation",
                "start": 212,
                "end": 221,
                "token_start": 36,
                "token_end": 36,
                "entityLabel": "O"
            },
            {
                "text": "hirsutism",
                "start": 223,
                "end": 232,
                "token_start": 38,
                "token_end": 38,
                "entityLabel": "F"
            },
            {
                "text": "endothelial dysfunction",
                "start": 237,
                "end": 260,
                "token_start": 40,
                "token_end": 41,
                "entityLabel": "D"
            },
            {
                "text": "lipodystrophies",
                "start": 266,
                "end": 281,
                "token_start": 44,
                "token_end": 44,
                "entityLabel": "D"
            }
        ],
        "relations": [
            {
                "child": 14,
                "head": 8,
                "relationLabel": "TREATS"
            }
        ]
    },
    {
        "document": "Localisation of heme oxygenase isoforms in allergic human nasal mucosa.",
        "tokens": [
            {
                "text": "nasal mucosa",
                "start": 58,
                "end": 70,
                "token_start": 8,
                "token_end": 9,
                "entityLabel": "T"
            },
            {
                "text": "human",
                "start": 52,
                "end": 57,
                "token_start": 7,
                "token_end": 7,
                "entityLabel": "H"
            },
            {
                "text": "allergic",
                "start": 43,
                "end": 51,
                "token_start": 6,
                "token_end": 6,
                "entityLabel": "P"
            },
            {
                "text": "heme oxygenase",
                "start": 16,
                "end": 30,
                "token_start": 2,
                "token_end": 3,
                "entityLabel": "Amino Acid, Peptide, or Protein"
            }
        ],
        "relations": [
            {
                "child": 7,
                "head": 8,
                "relationLabel": "PART_OF"
            }
        ]
    },
    {
        "document": "In conclusion, unlike iNOS, HO-1 is minimally expressed in the nasal respiratory epithelium of either group.",
        "tokens": [
            {
                "text": "respiratory epithelium",
                "start": 69,
                "end": 91,
                "token_start": 15,
                "token_end": 16,
                "entityLabel": "T"
            },
            {
                "text": "HO-1",
                "start": 28,
                "end": 32,
                "token_start": 6,
                "token_end": 6,
                "entityLabel": "Amino Acid, Peptide, or Protein"
            },
            {
                "text": "nasal",
                "start": 63,
                "end": 68,
                "token_start": 14,
                "token_end": 14,
                "entityLabel": "B"
            },
            {
                "text": "group",
                "start": 102,
                "end": 107,
                "token_start": 19,
                "token_end": 19,
                "entityLabel": "Population Group"
            }
        ],
        "relations": [
            {
                "child": 6,
                "head": 15,
                "relationLabel": "LOCATION_OF"
            }
        ]
    },
    {
        "document": "OBJECTIVE: To explore the impact of hydrogen sulfide (H2S) donor, sodium hydrosulfide (NaHS), on pulmonary vascular structure and vasoactive peptides in rats with pulmonary hypertension induced by high pulmonary blood flow.",
        "tokens": [
            {
                "text": "hydrogen sulfide",
                "start": 36,
                "end": 52,
                "token_start": 7,
                "token_end": 8,
                "entityLabel": "I"
            },
            {
                "text": "pulmonary vascular structure",
                "start": 97,
                "end": 125,
                "token_start": 21,
                "token_end": 23,
                "entityLabel": "B"
            },
            {
                "text": "peptides",
                "start": 141,
                "end": 149,
                "token_start": 26,
                "token_end": 26,
                "entityLabel": "A"
            },
            {
                "text": "rats",
                "start": 153,
                "end": 157,
                "token_start": 28,
                "token_end": 28,
                "entityLabel": "M"
            },
            {
                "text": "blood flow",
                "start": 212,
                "end": 222,
                "token_start": 36,
                "token_end": 37,
                "entityLabel": "O"
            }
        ],
        "relations": [
            {
                "child": 21,
                "head": 7,
                "relationLabel": "AFFECTS"
            }
        ]
    },
    {
        "document": "The morphologic changes including micro-and ultra-structural changes of pulmonary arteries of rats were observed under optical microscope and electro-microscope, respectively.",
        "tokens": [],
        "relations": []
    },
    {
        "document": "BACKGROUND: The relative effectiveness of second-generation (atypical) antipsychotic drugs as compared with that of older agents has been incompletely addressed, though newer agents are currently used far more commonly.",
        "tokens": [],
        "relations": []
    },
    {
        "document": "The fertilization calcium wave is then set into the context of cell cycle control, and the mechanism of repetitive calcium spiking in mammalian eggs is investigated.",
        "tokens": [
            {
                "text": "eggs",
                "start": 144,
                "end": 148,
                "token_start": 24,
                "token_end": 24,
                "entityLabel": "C"
            },
            {
                "text": "calcium spiking",
                "start": 115,
                "end": 130,
                "token_start": 2,
                "token_end": 3,
                "entityLabel": "C"
            },
            {
                "text": "mammalian",
                "start": 134,
                "end": 143,
                "token_start": 23,
                "token_end": 23,
                "entityLabel": "M"
            }
        ],
        "relations": [
            {
                "child": 2,
                "head": 24,
                "relationLabel": "LOCATION_OF"
            }
        ]
    },
    {
        "document": "Evidence that the Wingless/calcium signaling pathway is a strong ventralizing signal in Xenopus, mediated by phosphoinositide signaling, is adumbrated.",
        "tokens": [
            {
                "text": "phosphoinositide signaling",
                "start": 109,
                "end": 135,
                "token_start": 18,
                "token_end": 19,
                "entityLabel": "Biologically Active Substance"
            },
            {
                "text": "ventralizing signal",
                "start": 65,
                "end": 84,
                "token_start": 11,
                "token_end": 12,
                "entityLabel": "C"
            },
            {
                "text": "Xenopus",
                "start": 88,
                "end": 95,
                "token_start": 14,
                "token_end": 14,
                "entityLabel": "A"
            }
        ],
        "relations": [
            {
                "child": 11,
                "head": 18,
                "relationLabel": "AFFECTS"
            }
        ]
    },
    {
        "document": "In preterm lambs, intraamniotic endotoxin and interleukin 1 (IL-1) induce lung inflammation followed by lung maturation.",
        "tokens": [
            {
                "text": "interleukin 1",
                "start": 46,
                "end": 59,
                "token_start": 7,
                "token_end": 8,
                "entityLabel": "Amino Acid, Peptide, or Protein"
            },
            {
                "text": "lung inflammation",
                "start": 74,
                "end": 91,
                "token_start": 15,
                "token_end": 16,
                "entityLabel": "D"
            },
            {
                "text": "endotoxin",
                "start": 32,
                "end": 41,
                "token_start": 5,
                "token_end": 5,
                "entityLabel": "Carbohydrate"
            },
            {
                "text": "lambs",
                "start": 11,
                "end": 16,
                "token_start": 2,
                "token_end": 2,
                "entityLabel": "M"
            },
            {
                "text": "maturation",
                "start": 109,
                "end": 119,
                "token_start": 20,
                "token_end": 20,
                "entityLabel": "P"
            }
        ],
        "relations": [
            {
                "child": 15,
                "head": 7,
                "relationLabel": "CAUSES"
            }
        ]
    },
    {
        "document": "METHODS: Lung inflammation was induced by intraamniotic injection of endotoxin or IL-1.",
        "tokens": [
            {
                "text": "injection",
                "start": 56,
                "end": 65,
                "token_start": 8,
                "token_end": 8,
                "entityLabel": "T"
            },
            {
                "text": "Lung inflammation",
                "start": 9,
                "end": 26,
                "token_start": 2,
                "token_end": 3,
                "entityLabel": "D"
            },
            {
                "text": "endotoxin",
                "start": 69,
                "end": 78,
                "token_start": 10,
                "token_end": 10,
                "entityLabel": "Carbohydrate"
            },
            {
                "text": "IL-1",
                "start": 82,
                "end": 86,
                "token_start": 12,
                "token_end": 12,
                "entityLabel": "Amino Acid, Peptide, or Protein"
            }
        ],
        "relations": [
            {
                "child": 2,
                "head": 8,
                "relationLabel": "CAUSES"
            }
        ]
    },
    {
        "document": "We recently showed that the atypical PKC (aPKC) isozyme PKCiota is overexpressed in human non-small cell lung cancer (NSCLC) cells and that PKCiota plays a critical role in the transformed growth of the human lung adenocarcinoma A549 cell line in vitro and tumorigenicity in vivo.",
        "tokens": [
            {
                "text": "PKCiota",
                "start": 56,
                "end": 63,
                "token_start": 11,
                "token_end": 11,
                "entityLabel": "Amino Acid, Peptide, or Protein"
            },
            {
                "text": "isozyme",
                "start": 48,
                "end": 55,
                "token_start": 10,
                "token_end": 10,
                "entityLabel": "Amino Acid, Peptide, or Protein"
            },
            {
                "text": "tumorigenicity",
                "start": 257,
                "end": 271,
                "token_start": 46,
                "token_end": 46,
                "entityLabel": "P"
            },
            {
                "text": "human lung adenocarcinoma A549 cell line",
                "start": 203,
                "end": 243,
                "token_start": 15,
                "token_end": 20,
                "entityLabel": "C"
            },
            {
                "text": "cells",
                "start": 125,
                "end": 130,
                "token_start": 23,
                "token_end": 23,
                "entityLabel": "C"
            },
            {
                "text": "atypical PKC (aPKC)",
                "start": 28,
                "end": 47,
                "token_start": 5,
                "token_end": 9,
                "entityLabel": "Amino Acid, Peptide, or Protein"
            }
        ],
        "relations": [
            {
                "child": 10,
                "head": 11,
                "relationLabel": "ISA"
            }
        ]
    },
    {
        "document": "Here we provide compelling evidence that PKCiota is an oncogene in NSCLC based on the following criteria: (a) aPKCiota is overexpressed in the vast majority of primary NSCLC tumors; (b) tumor PKCiota expression levels predict poor survival in patients with NSCLC; (c) the PKCiota gene is frequently amplified in established NSCLC cell lines and primary NSCLC tumors; (d) gene amplification drives PKCiota expression in NSCLC cell lines and primary NSCLC tumors; and (e) disruption of PKCiota signaling with a dominant negative PKCiota allele blocks the transformed growth of human NSCLC cells harboring PKCiota gene amplification.",
        "tokens": [
            {
                "text": "PKCiota",
                "start": 41,
                "end": 48,
                "token_start": 6,
                "token_end": 6,
                "entityLabel": "Amino Acid, Peptide, or Protein"
            },
            {
                "text": "oncogene",
                "start": 55,
                "end": 63,
                "token_start": 9,
                "token_end": 9,
                "entityLabel": "G"
            },
            {
                "text": "NSCLC",
                "start": 67,
                "end": 72,
                "token_start": 11,
                "token_end": 11,
                "entityLabel": "N"
            },
            {
                "text": "tumors",
                "start": 174,
                "end": 180,
                "token_start": 31,
                "token_end": 31,
                "entityLabel": "N"
            },
            {
                "text": "aPKCiota",
                "start": 110,
                "end": 118,
                "token_start": 21,
                "token_end": 21,
                "entityLabel": "Amino Acid, Peptide, or Protein"
            },
            {
                "text": "tumor",
                "start": 186,
                "end": 191,
                "token_start": 36,
                "token_end": 36,
                "entityLabel": "N"
            },
            {
                "text": "patients",
                "start": 243,
                "end": 251,
                "token_start": 44,
                "token_end": 44,
                "entityLabel": "Patient or Disabled Group"
            },
            {
                "text": "cell line",
                "start": 330,
                "end": 339,
                "token_start": 60,
                "token_end": 61,
                "entityLabel": "C"
            },
            {
                "text": "gene amplification",
                "start": 371,
                "end": 389,
                "token_start": 53,
                "token_end": 54,
                "entityLabel": "G"
            },
            {
                "text": "allele",
                "start": 535,
                "end": 541,
                "token_start": 97,
                "token_end": 97,
                "entityLabel": "G"
            },
            {
                "text": "cells",
                "start": 587,
                "end": 592,
                "token_start": 105,
                "token_end": 105,
                "entityLabel": "C"
            }
        ],
        "relations": [
            {
                "child": 9,
                "head": 6,
                "relationLabel": "ISA"
            },
            {
                "child": 21,
                "head": 31,
                "relationLabel": "PRODUCES"
            }
        ]
    },
    {
        "document": "One patient was successfully cured by steroid therapy, while the other did not respond to steroid but oral mesalazine was effective.",
        "tokens": [],
        "relations": []
    },
    {
        "document": "Systemic lupus erythematosus is frequently accompanied by gastrointestinal symptoms, but colonic lesions are quite rare, and the regular treatment is not fixed yet.",
        "tokens": [
            {
                "text": "Systemic lupus erythematosus",
                "start": 0,
                "end": 28,
                "token_start": 0,
                "token_end": 2,
                "entityLabel": "D"
            },
            {
                "text": "gastrointestinal symptoms",
                "start": 58,
                "end": 83,
                "token_start": 7,
                "token_end": 8,
                "entityLabel": "S"
            },
            {
                "text": "colonic",
                "start": 89,
                "end": 96,
                "token_start": 11,
                "token_end": 11,
                "entityLabel": "B"
            },
            {
                "text": "lesions",
                "start": 97,
                "end": 104,
                "token_start": 12,
                "token_end": 12,
                "entityLabel": "F"
            }
        ],
        "relations": [
            {
                "child": 7,
                "head": 0,
                "relationLabel": "COEXISTS_WITH"
            },
            {
                "child": 12,
                "head": 11,
                "relationLabel": "LOCATION_OF"
            }
        ]
    }
]